MIRAVANT MEDICAL TECHNOLOGIES
10-Q, EX-27.1, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: MIRAVANT MEDICAL TECHNOLOGIES, 10-Q, 2000-08-11
Next: FIRST SOUTHERN BANCSHARES INC/DE, 10QSB, 2000-08-11



<TABLE> <S> <C>


<ARTICLE>                     5


<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
CONSOLIDATED  BALANCE SHEETS AND CONSOLIDATED  STATEMENTS OF OPERATIONS FOUND IN
THE COMPANY'S FORM 10-Q FOR  THE PERIOD ENDED JUNE 30, 2000, AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              Dec-31-2000
<PERIOD-START>                                 Jan-1-2000
<PERIOD-END>                                   Jun-30-2000
<CASH>                                         6,404
<SECURITIES>                                  20,945
<RECEIVABLES>                                  1,602
<ALLOWANCES>                                       0
<INVENTORY>                                        0
<CURRENT-ASSETS>                              30,512
<PP&E>                                        12,053
<DEPRECIATION>                                (8,975)
<TOTAL-ASSETS>                                37,171
<CURRENT-LIABILITIES>                          4,570
<BONDS>                                            0
                              0
                                        0
<COMMON>                                     155,964
<OTHER-SE>                                  (147,124)
<TOTAL-LIABILITY-AND-EQUITY>                  37,171
<SALES>                                            0
<TOTAL-REVENUES>                               2,929
<CGS>                                              0
<TOTAL-COSTS>                                 13,419
<OTHER-EXPENSES>                                   0
<LOSS-PROVISION>                                   0
<INTEREST-EXPENSE>                               888
<INCOME-PRETAX>                              (10,779)
<INCOME-TAX>                                       0
<INCOME-CONTINUING>                          (10,779)
<DISCONTINUED>                                     0
<EXTRAORDINARY>                                    0
<CHANGES>                                          0
<NET-INCOME>                                 (10,779)
<EPS-BASIC>                                    (0.59)
<EPS-DILUTED>                                  (0.59)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission